ZLAB Zai Lab Limited

NASDAQ
$24.98

Zai Lab Limited (ZLAB) is expected to report earnings on November 9, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of +31.1% since its last earnings release on August 6, 2026.

Zai Lab Limited Reported Earnings
Thursday, August 6, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 6:30 AM ET
Earnings Whisper
-
vs -
Rev est $119.87M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $25.36

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Zai Lab Limited

Zai Lab is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.